BDSX Biodesix
- 1.770
- -0.030-1.67%
Biodesix News
Biodesix | 4: Statement of changes in beneficial ownership of securities-Officer Vazquez Chris
Biodesix | 4: Statement of changes in beneficial ownership of securities-Officer Pestano Gary Anthony
Biodesix | 4: Statement of changes in beneficial ownership of securities-Officer O'Kane Kieran
Biodesix | 4: Statement of changes in beneficial ownership of securities-Officer Hutton Scott
Biodesix | 4: Statement of changes in beneficial ownership of securities-Officer Cowie Robin Harper
Biodesix | 4: Statement of changes in beneficial ownership of securities-Director Watts Charles M
Biodesix | SC 13G: Statement of acquisition of beneficial ownership by individuals-Telemark Asset Management, LLC(5.70%),Telemark Fund, LP(5.70%), etc.
Biodesix | 4: Statement of changes in beneficial ownership of securities-Director Watts Charles M
Biodesix | 4: Statement of changes in beneficial ownership of securities-Director MASSARANY HANY
Biodesix | 4: Statement of changes in beneficial ownership of securities-Officer O'Kane Kieran
Biodesix | 4: Statement of changes in beneficial ownership of securities-Officer Pestano Gary Anthony
Biodesix | 4: Statement of changes in beneficial ownership of securities-Director SCHULER JACK W
Biodesix | 4: Statement of changes in beneficial ownership of securities-Director Strobeck Matthew
Biodesix | 4: Statement of changes in beneficial ownership of securities-Officer Vazquez Chris
Biodesix | 4: Statement of changes in beneficial ownership of securities-Director Kennedy Lawrence T. Jr
Biodesix | 4: Statement of changes in beneficial ownership of securities-Director Kayyem Jon Faiz
Biodesix | 4: Statement of changes in beneficial ownership of securities-Officer Hutton Scott
Biodesix | 4: Statement of changes in beneficial ownership of securities-Director Franchi Jean M.
Biodesix | 4: Statement of changes in beneficial ownership of securities-Officer Cowie Robin Harper
Biodesix | 4: Statement of changes in beneficial ownership of securities-Director PATIENCE JOHN
Analysis
Price Target
No Data
No Data